Objective To describe and analyse the hospitalisation cost of patients with hip fracture under the influence of various factors and to provide references for Chinese national medical insurance policy.
Materials and methods All data were collected from the Chinese National Medical Data Centre database, which contained the hospitalisation data of 73 tertiary hospitals from 24 provinces. The included patients were first hospitalised with the main diagnosis of femoral neck or intertrochanteric fracture, and were discharged between 1 January 2014 and 31 December 2015. Secondary hospitalisation, multiple trauma or pathologic fracture (except for osteoporotic fracture) patients or patients with missing data were excluded. The impact of various factors on the cost was investigated using analysis of variance and multivariable linear regression analysis. The Gross Domestic Product per capita and average annual disposable income were obtained from the website of the National Bureau of Statistics.
Results 27 205 cases were included in the study. The mean cost of all patients was ¥53 440. 60–69 years age group had a significantly higher cost compared with 80 years and above age group. The mean cost of femoral neck fractures was lower than that of the patients with intertrochanteric fractures; the mean cost of hip replacement was higher than that of internal fixation, which showed a strong effect of the surgical approach to the cost. Patients in low-income provinces spent less than those in high-income provinces, while the gap between high-income and middle-income provinces were relatively small.
Conclusion The hospitalisation cost of hip fracture has become a great burden to the patients’ families. The Chinese medical insurance policy may need further consideration of the demographic and economic factors.
- hip fracture
- treatment cost
- treatment methods
- length of stay
- income level
- medical insurance
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Contributors YW did the data collect and analysis. HC did the text-proofing and revising. DZ directed the data analysis. DZ and PZ were in charge of revision, and were both principal investigators in charge of this study. All authors read and approved the final version for publication.
Funding This study was supported by Chinese National Ministry of Science and Technology 973 Project (No. 2014CB542201) and 863 Project (No. SS2015AA020501), and the National Natural Science Foundation (No. 31571235, 31571236, 31271284).
Competing interests None declared.
Patient consent Not required.
Ethics approval This study was approved by the ethical review committee of the Peking University People’s Hospital.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.